194 related articles for article (PubMed ID: 31484533)
21. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
22. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
23. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
24. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
26. Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma.
Feng J; Lan R; Cai G; Lin J; Wang X; Lin J; Han D
J Orthop Surg Res; 2016 Nov; 11(1):150. PubMed ID: 27881153
[TBL] [Abstract][Full Text] [Related]
27. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
28. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
29. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
30. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
31. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
35. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
36. A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma.
Ługowska I; Woźniak W; Klepacka T; Michalak E; Szamotulska K
Pediatr Blood Cancer; 2011 Jul; 57(1):63-8. PubMed ID: 21416580
[TBL] [Abstract][Full Text] [Related]
37. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
Zhao H; Wu Y; Chen Y; Liu H
Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
[TBL] [Abstract][Full Text] [Related]
39. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
